DRI
63
-9
FAST
50
-2
BBY
51
10
BAX
45
-3
HOG
31
-3
APA
46
4
CNP
62
15
DHI
22
-2
HAS
60
-3
GD
50
-3
ABT
53
-12
AAL
27
-12
BWA
36
-12
CA
18
-6
D
61
11
EMC
82
7
CVX
32
3
CSCO
69
3
BIIB
50
2
FSLR
47
-2
DRI
63
-9
FAST
50
-2
BBY
51
10
BAX
45
-3
HOG
31
-3
APA
46
4
CNP
62
15
DHI
22
-2
HAS
60
-3
GD
50
-3
ABT
53
-12
AAL
27
-12
BWA
36
-12
CA
18
-6
D
61
11
EMC
82
7
CVX
32
3
CSCO
69
3
BIIB
50
2
FSLR
47
-2
Financhill
Back

Veracyte Stock Predictions

Big exits started like this. So did Mode

Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Buy
58

VCYT
Veracyte

Last Price:
$26.74
Seasonality Move:
13.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Sold-out (twice) tech raise for accredited investors only

Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite

Veracyte Stock Forecast

  • Over the next 52 weeks, Veracyte has on average historically risen by 21.5% based on the past 11 years of stock performance.
  • Veracyte has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
  • Is Veracyte Stock Undervalued?
    The current Veracyte [VCYT] share price is $26.74. The Score for VCYT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • VCYT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Veracyte Stock Go Up Next Year?

  • Over the next 52 weeks, Veracyte has on average historically risen by 21.5% based on the past 11 years of stock performance.

Veracyte Stock Rating

Buy
58
Veracyte (VCYT) is a Buy

Is Veracyte overpriced?

  • Veracyte has risen higher in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%

Veracyte Stock Price History

Is VCYT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VCYT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
veracyte.com

52-Week Data

52-Week High:
47.32
52-Week Low:
19.73

Prediction Charts

Market Cap:
2.1B
Price in USD:
26.74
Volume:
929.7K
Beta:
1.51

Technical Analysis

SMA50:
30.07
SMA100:
34.60
SMA200:
35.20
52-Wk Change:
28.87%

Stock Predictions

  • Is Veracyte stock public?
    Yes, Veracyte is a publicly traded company.
  • What is the Veracyte stock quote today?
    The Veracyte stock price is 26.74 USD today.
  • How to buy Veracyte stock online?
    You can buy Veracyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-13 30.81 29.31 30.99 29.29
May-14 29.23 28.49 29.76 28.34
May-15 28.54 28.49 28.80 27.61
May-16 28.62 29.20 29.48 28.11
May-19 28.68 29.00 29.10 28.42
May-20 28.97 28.81 29.06 28.50
May-21 28.60 27.61 28.79 27.50
May-22 27.44 27.40 27.97 27.16
May-23 27.00 27.16 27.30 26.64
May-27 27.58 27.97 27.97 27.23
May-28 27.97 26.72 27.97 26.69
May-29 27.18 26.96 27.32 26.27
May-30 26.73 26.61 27.54 26.32
Jun-2 26.57 26.74 27.13 26.05

Veracyte Earnings

Veracyte Earnings Report: Per Share Veracyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Veracyte Forecast Revenue Growth

Veracyte Stock Analysis: Historical quarterly revenues per share for Veracyte and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.03 per share, an increase this year of $0.27 per share, and an increase next year of $0.05 per share.

* Veracyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.